%0 Journal Article
%T Everolimus-eluting stents in interventional cardiology
%A Townsend JC
%A Rideout P
%A Steinberg DH
%J Vascular Health and Risk Management
%D 2012
%I 
%R http://dx.doi.org/10.2147/VHRM.S23388
%X olimus-eluting stents in interventional cardiology Review (26022) Total Article Views Authors: Townsend JC, Rideout P, Steinberg DH Published Date June 2012 Volume 2012:8 Pages 393 - 405 DOI: http://dx.doi.org/10.2147/VHRM.S23388 Received: 28 January 2012 Accepted: 21 March 2012 Published: 27 June 2012 Jacob C Townsend, Phillip Rideout, Daniel H Steinberg Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA Abstract: Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evolution of drug-eluting stents with a focus on the safety, efficacy, and unique characteristics of everolimus-eluting stents.
%K everolimus-eluting stents
%K safety
%K efficacy
%U https://www.dovepress.com/everolimus-eluting-stents-in-interventional-cardiology-peer-reviewed-article-VHRM